Literature DB >> 20020312

Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.

Kunihiro Yamagata1, Hirofumi Makino, Tadao Akizawa, Kunitoshi Iseki, Sadayoshi Itoh, Kenjiro Kimura, Daisuke Koya, Ichiei Narita, Tetsuya Mitarai, Masanobu Miyazaki, Yoshiharu Tsubakihara, Tsuyoshi Watanabe, Takashi Wada, Osamu Sakai.   

Abstract

BACKGROUND: The continuous increase in the number of people requiring dialysis is a major clinical and socioeconomical issue in Japan and other countries. This study was designed to encourage chronic kidney disease (CKD) patients to consult a physician, enhance cooperation between nephrologists and general practices, and prevent the progression of kidney disease.
METHODS: Subjects comprise CKD patients aged between 40 and 74 years consulting a general physician, and patients in CKD stage 3 with proteinuria and diabetes or hypertension. This trial is a stratified open cluster-randomized study with two intervention groups: group A (weak intervention) and group B (strong intervention). We have recruited 49 local medical associations (clusters) in 15 different prefectures, which were classified into four regions (strata) based on the level of increase rate of dialysis patients. The patients in group A clusters were instructed initially to undergo treatment in accordance with the current CKD treatment guide, whereas patients in group B clusters were not only instructed in the same fashion but also received support from an information technology (IT)-based system designed to help achieve the goals of CKD treatment, consultation support centers, and consultations by dietitians visiting the local general practice offices. We assessed the rates of continued consultation, collaboration between general practitioners and nephrologists, and progression of CKD (as expressed by CKD stage).
CONCLUSION: Through this study, filling the evidence-practice gap by facilitating effective communication and supporting general physicians and nephrologists, we will establish a CKD care system and decrease the number of advanced-stage CKD patients.

Entities:  

Mesh:

Year:  2009        PMID: 20020312     DOI: 10.1007/s10157-009-0249-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  36 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Results in KEEP's first report show progress in early identification of CKD patients.

Authors:  Mark E Neumann
Journal:  Nephrol News Issues       Date:  2003-11

3.  Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study.

Authors:  Jasper J Brugts; Annemarieke M Knetsch; Francesco U S Mattace-Raso; Albert Hofman; Jacqueline C M Witteman
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

Review 4.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

5.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 6.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors:  G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

7.  Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening.

Authors:  Kunihiro Yamagata; Hideto Takahashi; Chie Tomida; Yoh Yamagata; Akio Koyama
Journal:  Nephron       Date:  2002-05       Impact factor: 2.847

8.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

9.  Proteinuria and the risk of developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  11 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

Review 2.  Role of chronic kidney disease in cardiovascular disease: are we different from others?

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2011-04-05       Impact factor: 2.801

Review 3.  Prevalence and incidence of chronic kidney disease stage G5 in Japan.

Authors:  Kunihiro Yamagata; Takashi Yagisawa; Shigeru Nakai; Masaaki Nakayama; Enyu Imai; Motoshi Hattori; Kunitoshi Iseki; Takashi Akiba
Journal:  Clin Exp Nephrol       Date:  2014-05-13       Impact factor: 2.801

4.  Effect of glomerular filtration rate and proteinuria on medical cost among screened subjects.

Authors:  Kunitoshi Iseki; Chiho Iseki; Issei Kurahashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2012-11-20       Impact factor: 2.801

5.  A practical approach of salt and protein restriction for CKD patients in Japan.

Authors:  Kunitoshi Iseki; Kunihiro Yamagata
Journal:  BMC Nephrol       Date:  2016-07-19       Impact factor: 2.388

6.  Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study.

Authors:  Mariko Tsuchida-Nishiwaki; Haruhito A Uchida; Hidemi Takeuchi; Noriyuki Nishiwaki; Yohei Maeshima; Chie Saito; Hitoshi Sugiyama; Jun Wada; Ichiei Narita; Tsuyoshi Watanabe; Seiichi Matsuo; Hirofumi Makino; Akira Hishida; Kunihiro Yamagata
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

Review 7.  Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012.

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2013-02-08       Impact factor: 2.801

8.  Budget impact analysis of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-Ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Tsuneo Konta; Shouichi Fujimoto; Ichiei Narita; Kenjiro Kimura; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-02-11       Impact factor: 2.801

9.  Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Kunitoshi Iseki; Sadayoshi Ito; Kenjiro Kimura; Eiji Kusano; Takanori Shibata; Kimio Tomita; Ichiei Narita; Tomoya Nishino; Yoshihide Fujigaki; Tetsuya Mitarai; Tsuyoshi Watanabe; Takashi Wada; Teiji Nakamura; Seiichi Matsuo
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

10.  Medical and Dental Visits of Chronic Kidney Disease-Diagnosed Participants Analyzed From the Specific Health Checkups Results in Japan: TAMA MED Project-CKD.

Authors:  Tomohiro Kaneko; Eitaro Kodani; Hitomi Fujii; Hiroyuki Nakamura; Hajime Sasabe; Yutaka Tamura; Shuichi Tsuruoka
Journal:  J Clin Med Res       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.